Infectious Disease Testing/Diagnostic Market - Forecast(2020 - 2025)

Report Code: HCR 0085 Report Format: PDF + Excel (Delivery in 48 Hrs)
Infectious Disease Testing/Diagnostic Market Overview
Infectious Disease Testing/Diagnostic Market size is estimated to be $16.4 billion in 2019, growing at a CAGR of 5.6% during the forecast period 2020-2025. An increase in the prevalence of infectious diseases such as HIV/AIDs, Hepatitis, STDs, and the growing adoption of suitable testing methods are driving the Infectious Disease Testing/Diagnostic Market during the forecast period 2020-2025. Infectious diseases are disorders caused by microorganisms such as bacteria, viruses, fungi, parasites among which some are harmless and some cause dangerous diseases. The infectious disease is passed from person to person or transmitted by insects or other animals and by consuming contaminated food or water or being exposed to organisms in the environment. Moreover, according to the World Health Organization, the Malaria Rapid Diagnostic Test (RDT) had greatly improved the management of malaria infections especially in remote areas with limited access to good quality microscopy services. Also, next-generation sequencing (NGS) holds the potential for improving clinical and public health microbiology along with identifying pathogens more rapidly and precisely than traditional methods.

Key Takeaways
  • Owing to low sanitary conditions and hygiene practices in the low- and middle-income countries, hepatitis is very high in these regions leading to an increased demand of Infectious Disease Testing/Diagnostic market.
  • Hospitals and Clinical Laboratories dominated the Infectious diseases testing/diagnostic market in 2019 owing to ease of facilities for testing.
  • In 2019, North America dominated the Infectious Disease Testing/Diagnostic Market owing to its increased health concern along with better health infrastructure and the presence of large clinical laboratories.
  • Increase in the prevalence of infectious diseases such as HIV/AIDs, hepatitis, influenza, tuberculosis, and others is a major factor driving the Infectious Diseases Testing Market during the forecast period 2020-2025.

By Types of Diseases- Segment Analysis 
By Types of Diseases Hepatitis is forecast to be the fastest growing with CAGR 3.6% during the forecast period 2020-2025. This is owing to the poor sanitary condition and hygiene practices in low- and middle-income countries leading to an increase demand of Infectious diseases testing market during the forecast period 2020-2025. Hepatitis is transmitted through ingestion of contaminated food and water or through direct contact of infected person. According to World Health Organization, hepatitis A caused approximately 7134 deaths in 2016. Also, the World Health Organization has set a goal to eliminate hepatitis B virus (HBV) and hepatitis C virus (HCV) infections as a majorly threat by 2030, which is defined as 80% patients receiving treatment, a 90% reduction in incidence and a 65% reduction in mortality compared to 2015 levels. Moreover, alternative testing tools including Point-of-Care testing (POC) and Dried-Blood-Spots (DBS) has emerged as alternative to gold standard immunoassays, that require access to sophisticated clinical laboratories and are playing a critical role in helping advance the WHO goal. COVID19 testing is gaining significant traction is estimated to make noteworthy impact on the market growth.

By End-User- Segment Analysis
In 2019, the Hospitals and Laboratories dominated the Infectious Disease Testing/Diagnostic Market owing to ease of facilities for testing. Also, technological advancement leading to rapid diagnostic test which are faster, more reliable, and more widely available are further propelling the infectious diseases testing market during the forecast period 2020-2025. Furthermore, the growth of this segment is majorly owing to the increasing number of test in laboratories and hospitals. Moreover, in April 2018 the researchers from University of Toronto had created a shoe-box sized laboratory that can do blood testing in remote, low resource settings, quickly determining from a drop of blood whether a person has antibodies to specific infectious disease.

Geography- Segment Analysis
North America accounts for 38% of the Infectious Disease Testing/Diagnostic Market share in 2019. Increasing health concerns along with the growing demand of advanced testing and a better healthcare structure is a driving its market growth. Furthermore, the presence of large number of clinical laboratories and ease of availability of technology advanced instruments in that region is further driving its market growth.

Drivers –Infectious Disease Testing/Diagnostic Market

  • Increase in the number of Infectious Disease
Increase in the number of infectious disease is a major factor driving the Infectious Disease Testing/Diagnostic markets during the forecast period 2020-2025. Infectious diseases can be transmitted in several ways from person to person by either insects or animals. Also, increase in the prevalence infectious diseases such as HIV/AIDs, hepatitis, influenza, tuberculosis and others is a major factor driving the Antibody Testing Market during the forecast period 2020-2025.

  • Increasing Research and Development
Increasing research and development is a key factor contributing to the Infectious Disease Testing/Diagnostic market during the forecast period 2020-2025. Infectious Disease Testing/Diagnostic is a procedure by which the causative agent of an infectious disease is identified and often characterized. Besides, it is solely based on clinical presentation or more rigorous diagnostics test such as culturing of infectious agent, microscopy, biological screens and molecular methods. Furthermore, the increasing threat of emerging and reemerging infectious diseases outbreaks demands research and development (R&D) of effective and fit-for-purpose tools and technologies such as vaccine, drugs, diagnostics, personal protective equipment (PPE) and medical devices.

Challenges – Infectious Disease Testing/Diagnostic Market

  • Lack of Skilled Professionals
Lack of skilled professionals is a major factor restraining the Infectious Disease Testing/Diagnostic Market during the forecast period 2020-2025. Large number of patients and a greater number of available tests is difficult to carry out owing to the lack of skilled professional. In May 2019, according to the Bureau of Labor Statistics the demand of lab workers has grown 13% in the last year, almost double the average of the other U.S. jobs. So, lack of skilled professional disrupts the smooth functioning of Infectious Disease Testing/Diagnostic and serves as a setback for its growth in the market during the forecast period 2020-2025.

Infectious Disease Testing/Diagnostic Market Industry Outlook
Merger & Acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Infectious Disease Testing/Diagnostic Market. In 2019, Infectious Disease Testing/Diagnostic top 10 companies are Abbott Laboratories, Danaher, Bio-Rad Laboratories, bioMérieux SA, F. Hoffmann-La Roche, BD, DiaSorin S.p.A., Meridian Bioscience, Inc., Quidel Corporation, and Thermo Fisher Scientific Inc. 

Developments:
  • In February 2020, Cepheid and Sherlock Biosciences collaborated to focus on molecular test for infectious disease, and oncology beginning with a proof-of-concept project focused on the detection of coronavirus.
  • In April 2018, Brief Chembio Diagnostic and Lumiradx collaborated to develop new point-of-care diagnostics test for infectious diseases.

1. Infectious Disease Testing/Diagnostic Market Overview
    1.1 Definitions and Scope
2. Infectious Disease Testing/Diagnostic Market - Executive Summary
    2.1 Market Revenue and Key Trends 
    2.2 Key trends by End Use
    2.3 Key trends by Geography
3. Infectious Disease Testing/Diagnostic Market –Comparative Analysis
    3.1 Product Benchmarking - Key companies
    3.2 Financials Analysis - Key Companies
    3.3 Market Share Analysis- Key Companies
    3.4 Patent Analysis 
    3.5 Pricing Analysis
4. Infectious Disease Testing/Diagnostic Market - Startup companies Scenario Premium (Premium) 
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Infectious Disease Testing/Diagnostic Market – Industry Market Entry Scenario Premium (Premium) 
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Infectious Disease Testing/Diagnostic Market Forces
    6.1 Market Drivers
    6.2 Market Constraints & Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Infectious Disease Testing/Diagnostic Market -Strategic analysis
    7.1 Value chain analysis 
    7.2 Opportunities analysis
    7.3 Market life cycle
8. Infectious Disease Testing/Diagnostic Market – By Products (Market Size –$Million/$Billion)
    8.1 Assays and Kits
    8.2 Instruments
    8.3 Software & Services 
9. Infectious Disease Testing/Diagnostic Market – By Types Of Disease (Market Size –$Million/$Billion)
    9.1 Influenza
    9.2 Hepatitis
    9.3 AIDs
    9.4 Tuberculosis
    9.5 Rabies
    9.6 Cholera
    9.7 Dengue
    9.8 COVID19
    9.9 Others
10. Infectious Disease Testing/Diagnostic Market – By Testing Technique (Market Size –$Million/$Billion)
    10.1 Immuno Diagnostics
    10.2 Biochemical Characterization
    10.3 Microscopy
    10.4 Polymerase Chain Reaction (PCR)
    10.5 Deoxyribonucleic Acid (DNA) Sequencing
    10.6 Microarrays
    10.7 Hybridization
    10.8 Others
11. Infectious Disease Testing/Diagnostic Market – By End-Use (Market Size –$Million/$Billion)
    11.1 Hospitals & Clinical Laboratories
    11.2 Diagnostic Clinics
    11.3 Ambulatory Surgical Centers
    11.4 Nursing Homes
    11.5 Blood Banks
    11.6 Research Institutes
    11.7 Others
12. Infectious Disease Testing/Diagnostic Market - By Geography (Market Size -$Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Canada
        12.1.3 Mexico
    12.2 Europe
        12.2.1 U.K.
        12.2.2 Germany
        12.2.3 France
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Rest of Europe
    12.3 Asia-Pacific
        12.3.1 China
        12.3.2 Japan
        12.3.3 South Korea
        12.3.4 India
        12.3.5 Australia & New Zealand
        12.3.6 Rest of APAC
    12.4 Rest of the World
        12.4.1 Middle East
        12.4.2 Africa
        12.4.3 South America
13. Infectious Disease Testing/Diagnostic Market - Entropy
14. Infectious Disease Testing/Diagnostic Market – Industry/Segment Competition Landscape  (Premium) 
    14.1. Market Share Analysis
        14.1.1 Global Market Share – Key Companies
        14.1.2 Market Share by Region – Key companies
        14.1.3 Market Share by Country- Key companies
        14.1.4 Best Practices for Companies
15. Infectious Disease Testing/Diagnostic Market – Key Company List by Country Premium (Premium)
16. Infectious Disease Testing/Diagnostic Market Company Analysis
    16.1 Company Revenue, Products, M&A, Developments
    16.2 Company 1
    16.3 Company 2
    16.4 Company 3
    16.5 Company 4
    16.6 Company 5
    16.7 Company 6
    16.8 Company 7 
    16.9 Company 8
    16.10 Company 9
    16.11 Company 10 and more
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables

Table 1: Infectious Disease Testing Market Overview 2019-2024
Table 2: Infectious Disease Testing Market Leader Analysis 2018-2019 (US$)
Table 3: Infectious Disease Testing Market Product Analysis 2018-2019 (US$)
Table 4: Infectious Disease Testing Market End User Analysis 2018-2019 (US$)
Table 5: Infectious Disease Testing Market Patent Analysis 2013-2018* (US$)
Table 6: Infectious Disease Testing Market Financial Analysis 2018-2019 (US$)
Table 7: Infectious Disease Testing Market Driver Analysis 2018-2019 (US$)
Table 8: Infectious Disease Testing Market Challenges Analysis 2018-2019 (US$)
Table 9: Infectious Disease Testing Market Constraint Analysis 2018-2019 (US$)
Table 10: Infectious Disease Testing Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Infectious Disease Testing Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Infectious Disease Testing Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Infectious Disease Testing Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Infectious Disease Testing Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Infectious Disease Testing Market Value Chain Analysis 2018-2019 (US$)
Table 16: Infectious Disease Testing Market Pricing Analysis 2019-2024 (US$)
Table 17: Infectious Disease Testing Market Opportunities Analysis 2019-2024 (US$)
Table 18: Infectious Disease Testing Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Infectious Disease Testing Market Supplier Analysis 2018-2019 (US$)
Table 20: Infectious Disease Testing Market Distributor Analysis 2018-2019 (US$)
Table 21: Infectious Disease Testing Market Trend Analysis 2018-2019 (US$)
Table 22: Infectious Disease Testing Market Size 2018 (US$)
Table 23: Infectious Disease Testing Market Forecast Analysis 2019-2024 (US$)
Table 24: Infectious Disease Testing Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Infectious Disease Testing Market, Revenue & Volume, By Type Of Disease, 2019-2024 ($)
Table 26: Infectious Disease Testing Market By Type Of Disease, Revenue & Volume, By Introduction, 2019-2024 ($)
Table 27: Infectious Disease Testing Market By Type Of Disease, Revenue & Volume, By Influenza, 2019-2024 ($)
Table 28: Infectious Disease Testing Market By Type Of Disease, Revenue & Volume, By Hepatitis, 2019-2024 ($)
Table 29: Infectious Disease Testing Market By Type Of Disease, Revenue & Volume, By AIDS, 2019-2024 ($)
Table 30: Infectious Disease Testing Market By Type Of Disease, Revenue & Volume, By Tuberculosis, 2019-2024 ($)
Table 31: Infectious Disease Testing Market, Revenue & Volume, By Testing Technique, 2019-2024 ($)
Table 32: Infectious Disease Testing Market By Testing Technique, Revenue & Volume, By Introduction, 2019-2024 ($)
Table 33: Infectious Disease Testing Market By Testing Technique, Revenue & Volume, By Immuno diagnostics, 2019-2024 ($)
Table 34: Infectious Disease Testing Market By Testing Technique, Revenue & Volume, By Biochemical Characterization, 2019-2024 ($)
Table 35: Infectious Disease Testing Market By Testing Technique, Revenue & Volume, By Microscopy, 2019-2024 ($)
Table 36: Infectious Disease Testing Market By Testing Technique, Revenue & Volume, By Polymerase Chain Reaction(PCR), 2019-2024 ($)
Table 37: Infectious Disease Testing Market, Revenue & Volume, By Industry, 2019-2024 ($)
Table 38: Infectious Disease Testing Market By Industry, Revenue & Volume, By Laboratories, 2019-2024 ($)
Table 39: Infectious Disease Testing Market By Industry, Revenue & Volume, By Nursing Homes, 2019-2024 ($)
Table 40: Infectious Disease Testing Market By Industry, Revenue & Volume, By Blood Banks, 2019-2024 ($)
Table 41: Infectious Disease Testing Market By Industry, Revenue & Volume, By Hospitals, 2019-2024 ($)
Table 42: Infectious Disease Testing Market By Industry, Revenue & Volume, By Research Labs, 2019-2024 ($)
Table 43: North America Infectious Disease Testing Market, Revenue & Volume, By Type Of Disease, 2019-2024 ($)
Table 44: North America Infectious Disease Testing Market, Revenue & Volume, By Testing Technique, 2019-2024 ($)
Table 45: North America Infectious Disease Testing Market, Revenue & Volume, By Industry, 2019-2024 ($)
Table 46: South america Infectious Disease Testing Market, Revenue & Volume, By Type Of Disease, 2019-2024 ($)
Table 47: South america Infectious Disease Testing Market, Revenue & Volume, By Testing Technique, 2019-2024 ($)
Table 48: South america Infectious Disease Testing Market, Revenue & Volume, By Industry, 2019-2024 ($)
Table 49: Europe Infectious Disease Testing Market, Revenue & Volume, By Type Of Disease, 2019-2024 ($)
Table 50: Europe Infectious Disease Testing Market, Revenue & Volume, By Testing Technique, 2019-2024 ($)
Table 51: Europe Infectious Disease Testing Market, Revenue & Volume, By Industry, 2019-2024 ($)
Table 52: APAC Infectious Disease Testing Market, Revenue & Volume, By Type Of Disease, 2019-2024 ($)
Table 53: APAC Infectious Disease Testing Market, Revenue & Volume, By Testing Technique, 2019-2024 ($)
Table 54: APAC Infectious Disease Testing Market, Revenue & Volume, By Industry, 2019-2024 ($)
Table 55: Middle East & Africa Infectious Disease Testing Market, Revenue & Volume, By Type Of Disease, 2019-2024 ($)
Table 56: Middle East & Africa Infectious Disease Testing Market, Revenue & Volume, By Testing Technique, 2019-2024 ($)
Table 57: Middle East & Africa Infectious Disease Testing Market, Revenue & Volume, By Industry, 2019-2024 ($)
Table 58: Russia Infectious Disease Testing Market, Revenue & Volume, By Type Of Disease, 2019-2024 ($)
Table 59: Russia Infectious Disease Testing Market, Revenue & Volume, By Testing Technique, 2019-2024 ($)
Table 60: Russia Infectious Disease Testing Market, Revenue & Volume, By Industry, 2019-2024 ($)
Table 61: Israel Infectious Disease Testing Market, Revenue & Volume, By Type Of Disease, 2019-2024 ($)
Table 62: Israel Infectious Disease Testing Market, Revenue & Volume, By Testing Technique, 2019-2024 ($)
Table 63: Israel Infectious Disease Testing Market, Revenue & Volume, By Industry, 2019-2024 ($)
Table 64: Top Companies 2018 (US$) Infectious Disease Testing Market, Revenue & Volume
Table 65: Product Launch 2018-2019 Infectious Disease Testing Market, Revenue & Volume
Table 66: Mergers & Acquistions 2018-2019 Infectious Disease Testing Market, Revenue & Volume


List of Figures

Figure 1: Overview of Infectious Disease Testing Market 2019-2024
Figure 2: Market Share Analysis for Infectious Disease Testing Market 2018 (US$)
Figure 3: Product Comparison in Infectious Disease Testing Market 2018-2019 (US$)
Figure 4: End User Profile for Infectious Disease Testing Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Infectious Disease Testing Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Infectious Disease Testing Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Infectious Disease Testing Market 2018-2019
Figure 8: Ecosystem Analysis in Infectious Disease Testing Market 2018
Figure 9: Average Selling Price in Infectious Disease Testing Market 2019-2024
Figure 10: Top Opportunites in Infectious Disease Testing Market 2018-2019
Figure 11: Market Life Cycle Analysis in Infectious Disease Testing Market
Figure 12: GlobalBy Type Of Disease Infectious Disease Testing Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy Testing Technique Infectious Disease Testing Market Revenue, 2019-2024 ($)
Figure 14: GlobalBy Industry Infectious Disease Testing Market Revenue, 2019-2024 ($)
Figure 15: Global Infectious Disease Testing Market - By Geography
Figure 16: Global Infectious Disease Testing Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 17: Global Infectious Disease Testing Market CAGR, By Geography, 2019-2024 (%)
Figure 18: North America Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 19: US Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 20: US GDP and Population, 2018-2019 ($)
Figure 21: US GDP – Composition of 2018, By Sector of Origin
Figure 22: US Export and Import Value & Volume, 2018-2019 ($)
Figure 23: Canada Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 24: Canada GDP and Population, 2018-2019 ($)
Figure 25: Canada GDP – Composition of 2018, By Sector of Origin
Figure 26: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 27: Mexico Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 28: Mexico GDP and Population, 2018-2019 ($)
Figure 29: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 30: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 31: South America Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 32: Brazil Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 33: Brazil GDP and Population, 2018-2019 ($)
Figure 34: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 35: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 36: Venezuela Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 37: Venezuela GDP and Population, 2018-2019 ($)
Figure 38: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 39: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 40: Argentina Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 41: Argentina GDP and Population, 2018-2019 ($)
Figure 42: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 43: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 44: Ecuador Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 45: Ecuador GDP and Population, 2018-2019 ($)
Figure 46: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 47: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 48: Peru Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 49: Peru GDP and Population, 2018-2019 ($)
Figure 50: Peru GDP – Composition of 2018, By Sector of Origin
Figure 51: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 52: Colombia Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 53: Colombia GDP and Population, 2018-2019 ($)
Figure 54: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 55: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 56: Costa Rica Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 57: Costa Rica GDP and Population, 2018-2019 ($)
Figure 58: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 59: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 60: Europe Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 61: U.K Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 62: U.K GDP and Population, 2018-2019 ($)
Figure 63: U.K GDP – Composition of 2018, By Sector of Origin
Figure 64: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 65: Germany Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 66: Germany GDP and Population, 2018-2019 ($)
Figure 67: Germany GDP – Composition of 2018, By Sector of Origin
Figure 68: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 69: Italy Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 70: Italy GDP and Population, 2018-2019 ($)
Figure 71: Italy GDP – Composition of 2018, By Sector of Origin
Figure 72: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 73: France Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 74: France GDP and Population, 2018-2019 ($)
Figure 75: France GDP – Composition of 2018, By Sector of Origin
Figure 76: France Export and Import Value & Volume, 2018-2019 ($)
Figure 77: Netherlands Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 78: Netherlands GDP and Population, 2018-2019 ($)
Figure 79: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 80: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 81: Belgium Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 82: Belgium GDP and Population, 2018-2019 ($)
Figure 83: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 84: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 85: Spain Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 86: Spain GDP and Population, 2018-2019 ($)
Figure 87: Spain GDP – Composition of 2018, By Sector of Origin
Figure 88: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 89: Denmark Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 90: Denmark GDP and Population, 2018-2019 ($)
Figure 91: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 92: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 93: APAC Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 94: China Infectious Disease Testing Market Value & Volume, 2019-2024
Figure 95: China GDP and Population, 2018-2019 ($)
Figure 96: China GDP – Composition of 2018, By Sector of Origin
Figure 97: China Export and Import Value & Volume, 2018-2019 ($) Infectious Disease Testing Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 98: Australia Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 99: Australia GDP and Population, 2018-2019 ($)
Figure 100: Australia GDP – Composition of 2018, By Sector of Origin
Figure 101: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 102: South Korea Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 103: South Korea GDP and Population, 2018-2019 ($)
Figure 104: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 105: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 106: India Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 107: India GDP and Population, 2018-2019 ($)
Figure 108: India GDP – Composition of 2018, By Sector of Origin
Figure 109: India Export and Import Value & Volume, 2018-2019 ($)
Figure 110: Taiwan Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 111: Taiwan GDP and Population, 2018-2019 ($)
Figure 112: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 113: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 114: Malaysia Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 115: Malaysia GDP and Population, 2018-2019 ($)
Figure 116: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 117: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 118: Hong Kong Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 119: Hong Kong GDP and Population, 2018-2019 ($)
Figure 120: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 121: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 122: Middle East & Africa Infectious Disease Testing Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 123: Russia Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 124: Russia GDP and Population, 2018-2019 ($)
Figure 125: Russia GDP – Composition of 2018, By Sector of Origin
Figure 126: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 127: Israel Infectious Disease Testing Market Value & Volume, 2019-2024 ($)
Figure 128: Israel GDP and Population, 2018-2019 ($)
Figure 129: Israel GDP – Composition of 2018, By Sector of Origin
Figure 130: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 131: Entropy Share, By Strategies, 2018-2019* (%) Infectious Disease Testing Market
Figure 132: Developments, 2018-2019* Infectious Disease Testing Market
Figure 133: Company 1 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 134: Company 1 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 135: Company 1 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 136: Company 2 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 137: Company 2 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 138: Company 2 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 139: Company 3 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 140: Company 3 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 141: Company 3 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 142: Company 4 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 143: Company 4 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 144: Company 4 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 145: Company 5 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 146: Company 5 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 147: Company 5 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 148: Company 6 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 149: Company 6 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 150: Company 6 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 151: Company 7 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 152: Company 7 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 153: Company 7 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 154: Company 8 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 155: Company 8 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 156: Company 8 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 157: Company 9 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 158: Company 9 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 159: Company 9 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 160: Company 10 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 161: Company 10 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 162: Company 10 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 163: Company 11 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 164: Company 11 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 165: Company 11 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 166: Company 12 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 167: Company 12 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 168: Company 12 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 169: Company 13 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 170: Company 13 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 171: Company 13 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 172: Company 14 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 173: Company 14 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 174: Company 14 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 175: Company 15 Infectious Disease Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 176: Company 15 Infectious Disease Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 177: Company 15 Infectious Disease Testing Market Net Sales Share, By Geography, 2018 (%)